other material
confidence high
sentiment neutral
materiality 0.45
Karyopharm reduces office space by 46,278 sq ft, extends lease for remaining space through 2030
Karyopharm Therapeutics Inc.
- Reduces leased premises by 46,278 rentable square feet (from 98,502 to 52,224) effective Sept 30, 2025.
- Term for remaining 52,224 sq ft extended five years through Sept 30, 2030, with annual rent escalation.
- Annual base rent for remaining space starts at $35.75/sq ft ($1.87M) and rises to $39.75/sq ft ($2.08M) by year 5.
- Landlord provides $2,219,520 tenant improvement allowance ($42.50/sq ft) for work in the retained premises.
- Tenant surrenders vacated portion on Sept 30, 2025, without required removal of certain initial alterations.